Vagifem
Links shared publicly online about this topic
Vagifem 25mcg to be discontinued - MPR
empr.com — “Novo Nordisk announced that Vagifem (estradiol hemihydrate vaginal tablets) 10mcg will become the only available formulation of Vagifem for the treatment of atrophic vaginitis. This action is in accordance with medical recommendations for women to use the lower effective estrogen dose to treat the symptoms of atrophic vaginitis due to menopause.” View full resource at empr.com
Most Recently Shared on May 20, 2010 at 2:46 pm By:
MPR News: Vagifem 25mcg to be discontinued: Novo Nordisk announced that Vagifem (estradiol hemihydrate vaginal tab... http://bit.ly/aG5nuE
Vagifem 25mcg to be discontinued - ONA
oncologynurseadvisor.com — “Novo Nordisk announced that Vagifem (estradiol hemihydrate vaginal tablets) 10mcg will become the only available formulation of Vagifem for the treatment of atrophic vaginitis. This action is in accordance with medical recommendations for women to use the lower effective estrogen dose to treat the symptoms of atrophic vaginitis due to menopause.” View full resource at oncologynurseadvisor.com
Most Recently Shared on May 20, 2010 at 3:23 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Vagifem 25mcg to be discontinued http://goo.gl/fb/iDNoO
FDA Approves 10 mcg Dose of Vagifem for the Treatment of Atrophic Vaginitis Due to Menopause
drugs.com — “Vagifem (estradiol vaginal tablets) is used to treat atrophic vaginitis. Includes Vagifem side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on December 2, 2009 at 11:33 pm By:
FDA Approves 10 mcg Dose of Vagifem for the Treatment of Atrophic Vaginitis Due to Menopause - http://bit.ly/4xvEUQ
Vagifem 10mcg approved for atrophic vaginitis due to menopause - MPR
empr.com — “The FDA has approved a 10mcg formulation of Vagifem (estradiol vaginal tablets, from Novo Nordisk) for the treatment of atrophic vaginitis due to menopause.” View full resource at empr.com
Most Recently Shared on December 3, 2009 at 4:58 pm By:
MPR News: Vagifem 10mcg approved for atrophic vaginitis due to menopause: The FDA has approved a 10mcg formulation ... http://bit.ly/63e21J
Comments of using Vagifem (study 6120792) - eHealthMe.com
ehealthme.com — “Stopped use after 9 weeks due to hair loss.After 6 weeks non use hair still shedding .When will this cease?” View full resource at ehealthme.com
Most Recently Shared on March 20, 2012 at 11:54 am By:
Stopped use after 9 weeks due to hair loss.After 6 weeks non use hair still shedding .When will this cease? http://t.co/BV8TSBly
Novo Nordisk Launches Vagifem(R) 10g , The Lowest Dose Of Local Oestrogen Available For Post-Menopausal Women With Vaginal Atrophy
medicalnewstoday.com — “Almost half (45%) of post-menopausal women suffer or have suffered from vaginal atrophy, manifested as vaginal discomfort, increased tendency of infection, and pain during sexual intercourse1. B” View full resource at medicalnewstoday.com
Most Recently Shared on October 28, 2010 at 10:40 am By:
Women's Health Line Health Site
Novo Nordisk Launches Vagifem(R) 10μg , The Lowest Dose Of Local Oestrogen Available For Post-Menopau... http://sns.ly/AKe51 #womenshealth
Subscription Center - News Archive
pharmalive.com — “Subscription Center - News Archive” View full resource at pharmalive.com
Most Recently Shared on December 2, 2009 at 7:33 pm By:
PharmaLive Pharma and Health News
FDA Approves Vagifem-http://tinyurl.com/yacztd9
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
MPR
eMPR.com provides up-to-date, concise drug information at the point-of-care.
-
OncologyNurseAdvisor
Oncology Nurse Advisor offers clinical updates and evidence-based guidance to the oncology nurse community and includes regular coverage of a variety of topics.
-
Drugs.com
Keeping you up to date with the latest medication news, FDA Medwatch alerts and new drug approvals.
Advertisement
